172 related articles for article (PubMed ID: 27666791)
1. Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency.
Muñoz-López A; Romero-Moya D; Prieto C; Ramos-Mejía V; Agraz-Doblas A; Varela I; Buschbeck M; Palau A; Carvajal-Vergara X; Giorgetti A; Ford A; Lako M; Granada I; Ruiz-Xivillé N; Rodríguez-Perales S; Torres-Ruíz R; Stam RW; Fuster JL; Fraga MF; Nakanishi M; Cazzaniga G; Bardini M; Cobo I; Bayon GF; Fernandez AF; Bueno C; Menendez P
Stem Cell Reports; 2016 Oct; 7(4):602-618. PubMed ID: 27666791
[TBL] [Abstract][Full Text] [Related]
2. Identification of genes transcriptionally responsive to the loss of MLL fusions in MLL-rearranged acute lymphoblastic leukemia.
van der Linden MH; Seslija L; Schneider P; Driessen EM; Castro PG; Stumpel DJ; van Roon E; de Boer J; Williams O; Pieters R; Stam RW
PLoS One; 2015; 10(3):e0120326. PubMed ID: 25793396
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene.
Menendez P; Catalina P; Rodríguez R; Melen GJ; Bueno C; Arriero M; García-Sánchez F; Lassaletta A; García-Sanz R; García-Castro J
J Exp Med; 2009 Dec; 206(13):3131-41. PubMed ID: 19995953
[TBL] [Abstract][Full Text] [Related]
4. miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia.
Malouf C; Antunes ETB; O'Dwyer M; Jakobczyk H; Sahm F; Landua SL; Anderson RA; Soufi A; Halsey C; Ottersbach K
Blood; 2021 Nov; 138(21):2066-2092. PubMed ID: 34111240
[TBL] [Abstract][Full Text] [Related]
5. MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199.
Benito JM; Godfrey L; Kojima K; Hogdal L; Wunderlich M; Geng H; Marzo I; Harutyunyan KG; Golfman L; North P; Kerry J; Ballabio E; Chonghaile TN; Gonzalo O; Qiu Y; Jeremias I; Debose L; O'Brien E; Ma H; Zhou P; Jacamo R; Park E; Coombes KR; Zhang N; Thomas DA; O'Brien S; Kantarjian HM; Leverson JD; Kornblau SM; Andreeff M; Müschen M; Zweidler-McKay PA; Mulloy JC; Letai A; Milne TA; Konopleva M
Cell Rep; 2015 Dec; 13(12):2715-27. PubMed ID: 26711339
[TBL] [Abstract][Full Text] [Related]
6. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
Bueno C; Torres-Ruiz R; Velasco-Hernandez T; Molina O; Petazzi P; Martinez A; Rodriguez V; Vinyoles M; Cantilena S; Williams O; Vega-Garcia N; Rodriguez-Perales S; Segovia JC; Quintana-Bustamante O; Roy A; Meyer C; Marschalek R; Smith AL; Milne TA; Fraga MF; Tejedor JR; Menéndez P
Blood; 2023 Nov; 142(20):1752-1756. PubMed ID: 37756522
[TBL] [Abstract][Full Text] [Related]
7. Enhanced hemato-endothelial specification during human embryonic differentiation through developmental cooperation between
Bueno C; Calero-Nieto FJ; Wang X; Valdés-Mas R; Gutiérrez-Agüera F; Roca-Ho H; Ayllon V; Real PJ; Arambilet D; Espinosa L; Torres-Ruiz R; Agraz-Doblas A; Varela I; de Boer J; Bigas A; Gottgens B; Marschalek R; Menendez P
Haematologica; 2019 Jun; 104(6):1189-1201. PubMed ID: 30679325
[TBL] [Abstract][Full Text] [Related]
8. Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly(I:C), but not to a single maternal immune activation.
Malouf C; Ottersbach K
Exp Hematol; 2019 Aug; 76():49-59. PubMed ID: 31381950
[TBL] [Abstract][Full Text] [Related]
9. Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.
Hawkins KE; Moschidou D; Faccenda D; Wruck W; Martin-Trujillo A; Hau KL; Ranzoni AM; Sanchez-Freire V; Tommasini F; Eaton S; De Coppi P; Monk D; Campanella M; Thrasher AJ; Adjaye J; Guillot PV
Mol Ther; 2017 Feb; 25(2):427-442. PubMed ID: 28153093
[TBL] [Abstract][Full Text] [Related]
10. Modeling Leukemia Stem Cells with Patient-Derived Induced Pluripotent Stem Cells.
Deslauriers AG; Kotini AG; Papapetrou EP
Methods Mol Biol; 2021; 2185():411-422. PubMed ID: 33165864
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming LCLs to iPSCs Results in Recovery of Donor-Specific Gene Expression Signature.
Thomas SM; Kagan C; Pavlovic BJ; Burnett J; Patterson K; Pritchard JK; Gilad Y
PLoS Genet; 2015 May; 11(5):e1005216. PubMed ID: 25950834
[TBL] [Abstract][Full Text] [Related]
12. Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia.
Kotini AG; Chang CJ; Chow A; Yuan H; Ho TC; Wang T; Vora S; Solovyov A; Husser C; Olszewska M; Teruya-Feldstein J; Perumal D; Klimek VM; Spyridonidis A; Rampal RK; Silverman L; Reddy EP; Papaemmanuil E; Parekh S; Greenbaum BD; Leslie CS; Kharas MG; Papapetrou EP
Cell Stem Cell; 2017 Mar; 20(3):315-328.e7. PubMed ID: 28215825
[TBL] [Abstract][Full Text] [Related]
13. Nuclear transcriptome profiling of induced pluripotent stem cells and embryonic stem cells identify non-coding loci resistant to reprogramming.
Fort A; Yamada D; Hashimoto K; Koseki H; Carninci P
Cell Cycle; 2015; 14(8):1148-55. PubMed ID: 25664506
[TBL] [Abstract][Full Text] [Related]
14. Direct reprogramming of murine fibroblasts to hematopoietic progenitor cells.
Batta K; Florkowska M; Kouskoff V; Lacaud G
Cell Rep; 2014 Dec; 9(5):1871-1884. PubMed ID: 25466247
[TBL] [Abstract][Full Text] [Related]
15. Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion.
Pan F; Sarno J; Jeong J; Yang X; Jager A; Gruber TA; Davis KL; Cleary ML
J Clin Invest; 2024 Jan; 134(1):. PubMed ID: 37917159
[TBL] [Abstract][Full Text] [Related]
16. Differential chondrogenic differentiation between iPSC derived from healthy and OA cartilage is associated with changes in epigenetic regulation and metabolic transcriptomic signatures.
Khan NM; Diaz-Hernandez ME; Chihab S; Priyadarshani P; Bhattaram P; Mortensen LJ; Guzzo RM; Drissi H
Elife; 2023 Jan; 12():. PubMed ID: 36715686
[TBL] [Abstract][Full Text] [Related]
17. Patient-Derived iPSCs Faithfully Represent the Genetic Diversity and Cellular Architecture of Human Acute Myeloid Leukemia.
Kotini AG; Carcamo S; Cruz-Rodriguez N; Olszewska M; Wang T; Demircioglu D; Chang CJ; Bernard E; Chao MP; Majeti R; Luo H; Kharas MG; Hasson D; Papapetrou EP
Blood Cancer Discov; 2023 Jul; 4(4):318-335. PubMed ID: 37067914
[TBL] [Abstract][Full Text] [Related]
18. Time-resolved gene expression profiling during reprogramming of C/EBPα-pulsed B cells into iPS cells.
Di Stefano B; Collombet S; Graf T
Sci Data; 2014; 1():140008. PubMed ID: 25977766
[TBL] [Abstract][Full Text] [Related]
19. Reprogramming and multi-lineage transdifferentiation attenuate the tumorigenicity of colorectal cancer cells.
Guo T; Wang J; Pang M; Liu W; Zhang X; Fan A; Liu H; Liu Q; Wei T; Li C; Zhao X; Lu Y
J Biol Chem; 2024 Jan; 300(1):105534. PubMed ID: 38072050
[TBL] [Abstract][Full Text] [Related]
20. Cell-Reprogramming-Inspired Dynamically Responsive Hydrogel Boosts the Induction of Pluripotency via Phase-Separated Biomolecular Condensates.
Zhu F; Yan N; Lu X; Xu J; Gu H; Liang J; Cheng K; Wang X; Ma X; Ma N; Zhao X; Chen C; Nie G
Adv Mater; 2024 May; 36(22):e2211609. PubMed ID: 36989141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
